CANELLA, Alessandro
 Distribuzione geografica
Continente #
NA - Nord America 2.318
EU - Europa 646
AS - Asia 348
SA - Sud America 3
AF - Africa 1
OC - Oceania 1
Totale 3.317
Nazione #
US - Stati Uniti d'America 2.315
CN - Cina 235
UA - Ucraina 168
PL - Polonia 130
TR - Turchia 98
DE - Germania 92
IT - Italia 90
GB - Regno Unito 71
FI - Finlandia 36
SE - Svezia 30
BE - Belgio 16
FR - Francia 8
IR - Iran 7
BR - Brasile 2
CA - Canada 2
HK - Hong Kong 2
IN - India 2
RO - Romania 2
VN - Vietnam 2
AU - Australia 1
CH - Svizzera 1
CL - Cile 1
IE - Irlanda 1
MT - Malta 1
MX - Messico 1
OM - Oman 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 3.317
Città #
Woodbridge 387
Fairfield 258
Chandler 200
Jacksonville 188
Houston 162
Warsaw 130
Ashburn 128
Wilmington 128
Ann Arbor 119
Seattle 103
Cambridge 93
Nanjing 58
Izmir 56
Princeton 41
Beijing 40
Milan 39
Boardman 34
New York 33
San Diego 25
Shanghai 22
Bremen 21
Dearborn 20
Shenyang 20
Brussels 16
Auburn Hills 14
Mountain View 13
Addison 12
Jinan 12
Los Angeles 12
Nanchang 12
Tianjin 12
Falls Church 11
Redwood City 9
San Mateo 9
Hebei 8
Zhengzhou 8
Changsha 7
Jiaxing 7
Leawood 7
Norwalk 7
Verona 7
Ardabil 6
Bologna 6
Des Moines 5
London 5
Padova 5
Cagliari 4
Ferrara 4
Guangzhou 4
Philadelphia 4
Augusta 3
Orange 3
Dong Ket 2
Edinburgh 2
Haikou 2
Hefei 2
Helsinki 2
Kunming 2
Lanzhou 2
Ningbo 2
São Paulo 2
Taiyuan 2
Taizhou 2
Toronto 2
Walnut 2
Washington 2
Wuhan 2
Acton 1
Buffalo 1
Dublin 1
Fuzhou 1
Garden Grove 1
Garza García 1
Gioia Del Colle 1
Hamburg 1
Hangzhou 1
Hounslow 1
Indiana 1
Kilburn 1
La Canada Flintridge 1
Melbourne 1
Monmouth Junction 1
Palermo 1
Phoenix 1
Redmond 1
Salalah 1
San Francisco 1
Southwark 1
Stockholm 1
Valletta 1
Zola Predosa 1
Zurich 1
Totale 2.592
Nome #
HIV-1 Tat protein modulates the generation of cytotoxic T cell epitopes by modifying proteasome composition and enzymatic activity 253
VITAMIN K-INDUCED MODIFICATION OF COAGULATION PHENOTYPE IN VKORC1 HOMOZYGOUS DEFICIENCY 136
Biologically active platinum complexes containing 8-thiotheophylline and 8-(methylthio)theophylline 128
Arecoline tripeptide inhibitors of proteasome 119
Osteogenic potential of cells derived from nasal septum 117
Mesenchymal stem cells from patients to assay bone graft substitutes 114
C(5) modified uracil derivatives showing antiproliferative and erythroid differentiation inducing activities on human chronic myelogenous leukemia K562 cells 113
Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency 113
Effective hemostasis during minor surgery in a case of hereditary combined deficiency of vitamin K-dependent clotting factors 112
Ribosome readthrough accounts for secreted full-length factor IX in hemophilia B patients with nonsense mutations 109
Phosphinic platinum complexes with 8-thiotheophylline derivatives: Synthesis, characterization, and antiproliferative activity 107
The lifespan of major histocompatibility complex class I/peptide complexes determines the efficiency of cytotoxic T-lymphocyte responses 106
Formation of L-Threonic Acid from L-Ascorbic Acid Oxidative Ring Opening and its Coordination to PtII: X-ray Crystal Structures of [Pt(threonato-O,O)-(PPh3)2] and [Pt(oxalato)(PPh3)2] 106
The Toll-like receptor ligand MALP-2 stimulates dendritic cell maturation and modulates proteasome composition and activity 97
Water-Soluble Cp Ruthenium Complex Containing1,3,5-Triaza-7-phosphaadamantane and 8-Thiotheophylline Derivatives:Synthesis, Characterization, and Antiproliferative Activity 96
Influence of obstetric factors on osteogenic potential of umbilical cord-derived mesenchymal stem cells 96
Characterization of the intracellular signalling capacity of natural FXa mutants with reduced pro-coagulant activity 93
null 90
Development of K562 cell clones expressing beta-globin mRNA carrying the beta039 thalassemia mutation for the screening of correctors of stop codon mutations 89
null 89
Production of β-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous β039 thalassemia patients 87
Non-conventional therapeutic strategies for inherited disorders oh hemostasis 87
Interaction of occupational posture, lifestyle and genetic components of thrombophilia 79
Association of the homozygous nonsense mutation R402X in coagulation factor VII with asymptomatic phenotype 69
High Porosity Bioceramic is a Favourable Environment for the Adhesion and Proliferation of Human Mesenchymal Stem Cells. 68
Production of s-globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous s039 thalassemia patients 68
null 62
Proteasome inhibitors: synthesis and activity of arecoline oxide tripeptide derivatives 61
Characterization of PAR-mediated signaling induced by activated coagulation factor X mutants 57
Readthrough of the premature stop codon beta039-thalassemia 57
The FVII R402X nonsense mutation, associated with an asymptomatic phenotype, is responsible for small amounts of circulating protein with improved coagulant activity 55
Non-conventional therapeutic strategies for inherited disorders of hemostasis 53
null 49
null 46
The pan-HDAC inhibitor AR42 downregulates CD44 expression, a new circulating prognostic factor for multiple myeloma 46
RNA−based therapeutic approaches for blood coagulation factor deficiencies caused by splicing mutations 25
Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals 24
New Coordination Modes of L-Ascorbic Acid and Dehydro-L-ascorbic Acid as Dianionic Chelating Ligand for Platinum 19
Selective amino acid substitutions of a subdominant Epstein-Barr virus LMP2-derived epitope increase HLA/peptide complex stability and immunogenicity: implications for immunotherapy of Epstein-Barr virus-associated malignancies 16
Hybrid alpha-bromoacryloylamido chalcones. Design, synthesis and biological evaluation 15
Naturally occurring truncated proteins: decreased protein secretion and increased activity result in asymptomatic coagulation factor deficiency 13
Supra-agonist peptides enhance the reactivation of memory CTL responses 9
Totale 3.348
Categoria #
all - tutte 11.415
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.415


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019288 0 0 0 0 0 0 0 0 0 0 101 187
2019/2020759 126 33 25 100 52 97 59 76 57 72 44 18
2020/2021477 44 45 29 57 21 44 12 61 4 57 73 30
2021/2022413 12 49 29 16 17 12 23 23 11 27 42 152
2022/2023476 45 33 17 61 86 65 42 38 51 3 17 18
2023/2024157 20 23 17 5 7 49 11 15 4 6 0 0
Totale 3.348